Asian patients with melanoma were found to have lower levels of certain ICI therapeutic targets (PD-L1, CTLA-4, and IDO-1) than Caucasian patients in an analysis of RNA sequencing expression profiles [37]. The gene discussed is CTLA4; the disease is melanoma.